Barcelonaβeta Brain Research Center

Implementation of subjective cognitive decline criteria in research studies

José Luís Molinuevo, Laura A. Rabin, Rebecca E. Amariglio et al. · Alzheimer s & Dementia · 2016 · 552 citations · Full text

Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s <i>continuum</i> when only subtle changes in Aβ pathology are detected

Marc Suárez‐Calvet, Thomas K. Karikari, Nicholas J. Ashton et al. · EMBO Molecular Medicine · 2020 · 392 citations · Full text

Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline

Juan Lantero‐Rodriguez, Thomas K. Karikari, Marc Suárez‐Calvet et al. · Acta Neuropathologica · 2020 · 363 citations · Full text

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative

Thomas K. Karikari, Andréa Lessa Benedet, Nicholas J. Ashton et al. · Molecular Psychiatry · 2020 · 360 citations

Neuroimaging Biomarkers, Neurodegenerative Diseases, Alzheimer's Disease +12

Long-term exposure to residential green and blue spaces and anxiety and depression in adults: A cross-sectional study

Mireia Gascón, Gonzalo Sánchez‐Benavides, Payam Dadvand et al. · Environmental Research · 2018 · 354 citations

Built Environment, Housing, Urban Green Spaces +13